[{"uuid": "1ad7bf31-5014-3473-abbe-13504ba9be06", "title": "Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman\u2019s Long-Term Stock Picks?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/aldeyra-therapeutics-aldx-among-billionaire-202812864.html", "providerPublishTime": 1737404892, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/AzdM81UWrKOtl6u4TUOTIA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/57ea2aa88d4a2a510fe5de82a4e2f310", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8LuW5b0XIBz1VNyqxme3Qg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/57ea2aa88d4a2a510fe5de82a4e2f310", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALDX"]}, {"uuid": "a9e7b158-b371-3233-9788-5a219052a746", "title": "3 US Penny Stocks With Market Caps Over $80M To Watch", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/3-us-penny-stocks-market-000916579.html", "providerPublishTime": 1735690156, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/FEoWkW5.iY._1qhNsHijRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/022699753fad0dede80810c245e79274", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VoPmPqK1nhnCQ7S1hUVKBw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/022699753fad0dede80810c245e79274", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALDX", "KNDI", "ANL"]}, {"uuid": "288ddc6e-87f1-3b0e-bd83-972bff157b83", "title": "Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/options-market-predicting-spike-aldeyra-150500800.html", "providerPublishTime": 1733756700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1H9NqoSNLfLtMd2fyMlfBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Qgti4EPNLR_lkjc6rmzFnw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALDX"]}, {"uuid": "1972a31c-c9c5-38ea-a2b3-c146d8314894", "title": "ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/aldx-fda-accepts-resubmitted-nda-150000461.html", "providerPublishTime": 1732028400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4qYAeIby_0fxQYGokmloZw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/_cD2UyIEHIJ5d.vXrEcDjQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALDX", "ABBV"]}, {"uuid": "2c5f9032-8130-3d15-acbd-ec5385ec2b12", "title": "High Growth Tech Stocks To Watch In December 2024", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-180251644.html", "providerPublishTime": 1734717771, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/IO2v6Az9Ftp5BwGxWk_U3A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8dd43bf33c3f09b3bd16e76b99877c31", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/w9ZxkxK11mrr5o.l0d5wwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8dd43bf33c3f09b3bd16e76b99877c31", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA", "ALDX", "INFN"]}, {"uuid": "0423cf1b-eb79-3318-8db9-a42d4288d73c", "title": "Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aldeyra-therapeutics-announces-fda-acceptance-120000642.html", "providerPublishTime": 1731931200, "type": "STORY", "relatedTickers": ["ALDX"]}, {"uuid": "52b301de-fa56-3fb2-8f8c-5491fc03b751", "title": "Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aldeyra-therapeutics-participate-citi-2024-120000904.html", "providerPublishTime": 1733140800, "type": "STORY", "relatedTickers": ["ALDX"]}, {"uuid": "86165410-d369-3132-a30c-e7351746f954", "title": "Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aldeyra-therapeutics-apos-resubmitted-marketing-130103483.html", "providerPublishTime": 1731934863, "type": "STORY", "relatedTickers": ["ALDX", "ABBV"]}, {"uuid": "fc17d404-eb38-3d98-9e86-1606914e7997", "title": "Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aldeyra-therapeutics-participate-jefferies-london-120000664.html", "providerPublishTime": 1731585600, "type": "STORY", "relatedTickers": ["ALDX"]}, {"uuid": "b708afb7-aaaa-3e92-8886-795b2f475b95", "title": "Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bellring-brands-brbr-outperforming-other-144013421.html", "providerPublishTime": 1731422413, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gUf3JPAiwp3PVjuDKftvaA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9", "width": 900, "height": 845, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HpYEBsELOHKKt9_5_oEt0Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BRBR", "ALDX"]}, {"uuid": "300351b2-e0ab-3a2a-875e-686e9a70eb99", "title": "Top US Penny Stocks To Watch In November 2024", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/top-us-penny-stocks-watch-130609889.html", "providerPublishTime": 1732107969, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_9EAYQzz7lxwJ6vgslF8Uw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ae61b9d9279ae16dce370df1ad69157b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/29EgMU1pJEMcTLiXbu6lwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ae61b9d9279ae16dce370df1ad69157b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HYLN", "ALDX", "ADV", "ADVWW"]}]